Matt Might

Matthew Might is the director of the Hugh Kaul Personalized Medicine Institute at the University of Alabama Birmingham.

Might received his bachelor's in 2001 and PhD in 2007 from Georgia Tech, both in computer science. In 2008, he joined the faculty at the University of Utah, where he worked as a professor of computer science and pharmaceutical chemistry until 2017. He was a visiting professor of biomedical informatics at Harvard Medical School.

Might is a White House strategist for the Precision Medicine Initiative and an advisor for the Undiagnosed Diseases Network. In 2017, he was given a Rare Impact Award by the National Organization for Rare Disorders. Might is the Chief Scientific Officer of the NGLY1 Foundation.

Research

Might's early work focused on cybersecurity. In recent years, he has transitioned to personalized medicine and bioinformatics.

Might wrote a blog post that went viral after his son, Bertrand, was diagnosed with NGLY1 deficiency, a rare disease that was previously unknown. This widespread publicity allowed him to locate several other patients and generate data on the characteristics of the disease.

Might used an artificial intelligence system he was developing called mediKanren to find out that Bertrand had Pseudomonas during a time when he was in critical condition.

Personal life

Might is married to Cristina Casanova and has three children. His father was the president and CEO of Cable One, the cable-television division of the former Washington Post Company. His wife is the daughter of Manuel Casanova.